NCT06628154View on ClinicalTrials.gov

Losartan and Emotional Learning

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 14, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Emotional Processing
Interventions
DRUG

Losartan potassium 50mg

Single dose losartan (50 mg, weight-adjusted), encapsulated identically to placebo

OTHER

Placebo

Single tablet encapsulated identically to losartan

Trial Locations (1)

OX37JX

RECRUITING

Warneford Hospital, University of Oxford, Oxford

All Listed Sponsors
collaborator

Oxford Health Biomedical Research Centre (OH BRC) support scheme

UNKNOWN

lead

University of Oxford

OTHER